Shares of Smiths Group plc (LON:SMIN) dropped 3.1% during trading on Thursday . The stock traded as low as GBX 1,504.50 ($21.10) and last traded at GBX 1,506 ($21.12). Approximately 1,194,160 shares were traded during mid-day trading, a decline of 10% from the average daily volume of 1,330,000 shares. The stock had previously closed at GBX 1,554 ($21.79).

SMIN has been the subject of several recent analyst reports. Numis Securities raised shares of Smiths Group to an “add” rating and set a GBX 1,725 ($24.19) target price for the company in a research note on Friday, January 12th. Credit Suisse Group reaffirmed an “outperform” rating and issued a GBX 1,730 ($24.26) target price on shares of Smiths Group in a research note on Friday, December 8th. Deutsche Bank reaffirmed a “buy” rating and issued a GBX 1,750 ($24.54) target price on shares of Smiths Group in a research note on Monday, December 4th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a GBX 1,800 ($25.24) target price on shares of Smiths Group in a research note on Wednesday, November 15th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Smiths Group currently has a consensus rating of “Buy” and an average price target of GBX 1,770 ($24.82).

The stock has a market capitalization of $5,940.00 and a price-to-earnings ratio of 1,056.34.

In related news, insider George Buckley purchased 782 shares of the firm’s stock in a transaction on Thursday, February 1st. The shares were bought at an average price of GBX 1,599 ($22.42) per share, for a total transaction of £12,504.18 ($17,532.50).

COPYRIGHT VIOLATION WARNING: This piece was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at

Smiths Group Company Profile

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.

Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with's FREE daily email newsletter.